The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Karvezide



Sanofi-Aventis GroupeEU/1/98/085/023-028

Main Information

Trade NameKarvezide
Active SubstancesIrbesartan
Hydrochlorothiazide
Dosage FormFilm-coated tablet
Licence HolderSanofi-Aventis Groupe
Licence NumberEU/1/98/085/023-028

Group Information

ATC CodeC09DA Angiotensin II antagonists and diuretics
C09DA04 irbesartan and diuretics

Status

License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back